|
J Biol Chem, Vol. 273, Issue 34, 21455-21462, August 21, 1998
Prodigiosins as a New Group of H+/Cl
Symporters That Uncouple Proton Translocators*
Tomohiko
Sato ,
Hiroki
Konno ,
Yasufumi
Tanaka ,
Takao
Kataoka§,
Kazuo
Nagai§,
Harry H.
Wasserman¶, and
Shoji
Ohkuma
From the Laboratory of Biochemistry, Department of
Molecular and Cell Biology, Faculty of Pharmaceutical Sciences,
Kanazawa University, Takara-machi 13-1, Kanazawa, Ishikawa 920-0934, Japan, the § Department of Bioengineering, Tokyo Institute
of Technology, Nagatsuta-chou 4259, Midori-ku, Yokohama, Kanagawa
226-0026, Japan, and the ¶ Department of Chemistry, Yale
University, New Haven, Connecticut 06520-8107
 |
ABSTRACT |
We reported previously (Kataoka, T., Muroi, M.,
Ohkuma, S., Waritani, T., Magae, J., Takatsuki, A., Kondo, S.,
Yamasaki, M., and Nagai, K. (1995) FEBS Lett. 359, 53-59)
that prodigiosin 25-C uncoupled vacuolar H+-ATPase,
inhibited vacuolar acidification, and affected glycoprotein processing.
In the present study we show that prodigiosins (prodigiosin, metacycloprodigiosin, and prodigiosin 25-C) inhibit the acidification activity of H+-ATPase chloride dependently, but not
membrane potential formation or ATP hydrolysis activity, and suggest
that they promote H+/Cl symport (or
OH /Cl exchange, in its equivalence) across
vesicular membranes. In fact, prodigiosins displayed
H+/Cl symport activity on liposomal
membranes. First of all, they decreased the internal pH of liposomes
depending on the external chloride, and raised it depending on the
internal chloride when external buffer was free from chloride. Second,
their effect was electroneutral and not seriously affected by the
application of an inside positive membrane potential generated by
K+ and valinomycin. Finally, they promoted the uptake of
[36Cl] from external buffers with concomitant
intraliposomal acidification when external pH was acidic relative to
liposome interior. As prodigiosins hardly inhibit the catalytic
activity (ATP hydrolysis) unlike well known
OH /Cl exchangers (for example, tributyltin
chloride), they should provide powerful tools for the study of
molecular machinery and cellular activities involving transport of
protons and/or chloride.
 |
INTRODUCTION |
Prodigiosins are a group of red pigments produced by
microorganisms like Streptomyces and Serratia
(1). They show a wide variety of biological activities involving
selective inhibition of T cell proliferation induced by concanavalin A
(2, 3), immunomodulation in immunized mice (4-6), and suppression of the bone resorption by osteoclasts (7). We reported previously that
prodigiosin 25-C raises lysosomal pH and suppresses glycoprotein processing due to its uncoupling effect on vacuolar (lysosomal) H+-ATPase without showing apparent protonophoric activity
(8). Although prodigiosin 25-C also affects mitochondrial F-ATPase and
produces swelling of mitochondria besides Golgi, it did not affect the
cellular ATP level, showing relatively specific perturbation of
vacuolar pH when treated in vivo, which makes it a promising drug for the analysis of vacuolar function.
In the present paper, we show that H+/Cl
symport activity is expressed even on liposomal membranes and present
evidence that prodigiosins are a new group of
H+/Cl symporters (or
OH /Cl exchangers, in their equivalence)
that uncouple (dissociate) proton translocation from otherwise coupled
catalysis (for example, ATP hydrolysis) in such a way that they inhibit
acidification but neither catalysis nor membrane potential
formation. A preliminary account of this work was presented in the
22nd Meeting of the Japan Bioenergetics Group (9).
 |
EXPERIMENTAL PROCEDURES |
Materials--
Prodigiosin was prepared from the culture broth
of Serratia marsescens as described (10) and
metacycloprodigiosin and prodigiosin 25-C were obtained from
Streptomyces hiroshimensis (11). Rats (Wistar, male) were
obtained from Sankyo Labo Service (Tokyo, Japan). Fluorescein-labeled
dextran (FD) was either synthesized according to Ref. 12 or supplied in
the form of fluorescein isothiocyanate-dextran
(Mr 70,000) from Sigma. Triton WR-1339 was
obtained from Ruger Chemical Co. (Irvington, NJ).
n-Octyl- -D-thioglucoside was purchased from
Dojin (Kumamoto, Japan). Protease inhibitors of microbial origin were
obtained from the Peptide Research Institute (Osaka). Bafilomycin
A1 was kindly provided by Professor K. Altendorf (University of Osnabrück, Osnabrück, Germany).
Phospholipids were obtained from Sigma (Sigma type II-S
phosphatidylcholine from soybean phospholipids) and used without
purification. Pyranine (8-hydroxy-1,3,6-pyrenetrisulfonic acid,
trisodium salt, laser grade) was supplied from Eastman Kodak
Co.(Rochester, NY), and bis(3-phenyl-5-oxoisoxazol-4-yl)pentamethine
oxonol (Oxonol-V) and dipropylthiodicarbocyanine iodide
(diS-C3-(5)) were from Nippon Kanko Shikiso (Okayama).
Chlorine 36 (36Cl) was obtained from Amersham as sodium
chloride solution (3.8 MBq/ml, 103 µCi/ml). ClearsolTM
was obtained from NEN Life Science Products Inc. (Wilmington, DE)
through Dai-ichi radio isotope (Tokyo). Nigericin, carbonyl cyanide
p-trifluoromethoxyphenylhydrazone,
MES,1 HEPES,
tetramethylammonium hydroxide (TMAH), sodium gluconate, and
glucono- -lactone were supplied by Sigma. Other reagents were purchased as commercial products mostly from Sigma.
Preparation of Lysosomes (Dextranosomes) and Solubilization of
Lysosomal V-ATPase--
Preparation of fluorescein-dextran loaded
lysosomes (FD-dextranosomes) from rat liver was performed as described
(13), with the exception that the Percoll washout procedure was omitted
and the lysosomal layer in the Percoll gradient was used for the
experiments. Bovine chromaffin granules were obtained as described
(14). Lysosomal V-ATPase was solubilized from membrane ghosts of
Triton-filled lysosomes (tritosomal membrane ghosts, TMG) with
n-octyl- -D-thioglucoside in the presence of asolectin
(15).
Proton Pump Assay--
The formation of a pH gradient (inside
acid) was measured by means of the fluorescence quenching of FD
incorporated into lysosomes (intact lysosomes) (16-18) or the permeant
basic dye acridine orange (chromaffin granules). The formation of a
transmembrane potential gradient (inside positive) was measured by the
recovery of fluorescence quenching of diS-C3-(5) (intact
lysosomes) (19). The assay buffer, unless otherwise indicated,
contained 0.1 M KCl, 0.2 M sucrose, 20 mM HEPES-TMAH (pH 7.5), 0.5 mM
MgCl2, and 1 mM ATP-Na2 in a final
volume of 2.0 ml with or without the dyes. The concentrations of the
dyes were 1 µM for acridine orange and 0.5 µM for diS-C3-(5). Fluorescence was measured
at 37 °C with a Hitachi 850 or F-4500 spectrofluorometer with
excitation at 495 nm and emission at 520 nm for FD, 480 and 520 nm for
acridine orange, and 620 and 670 nm for diS-C3-(5),
respectively, with a 5-nm slit width for both monochrometers. The
initial velocity of acidification and membrane potential formation was
defined by the rate of ATP-dependent quenching of
fluorescence.
ATPase Assay--
ATPase (bafilomycin A1-sensitive
ATPase) assays were performed as described (15). The assay buffer
contained 0.1 M KCl, 0.2 M sucrose, 40 mM HEPES-TMAH (pH 7.5), 0.5 mM
MgCl2, and 1 mM ATP-Na2 in a final
volume of 1.0 ml and the reaction mixture was incubated at 30 °C for
40 min. The liberated phosphate was estimated by the malachite green
method (20). All data shown are the averages (with deviation of less
than 5%) of duplicate experiments.
Preparation of Liposomes--
Liposomes were prepared from
phosphatidylcholine essentially as described (21, 22): briefly,
phosphatidylcholine (Sigma type II-S phospholipids, a so called
asolectin) was suspended in a buffer (50 mg/ml, usually 2 ml), vortexed
vigorously, and sonified for clarity at room temperature for 5 min in
20 mM HEPES-TMAH (pH 7.5) containing 25 mM of
the desired salt, with or without (for anion requirement) 2.5 mM MgSO4 and then applied onto a spin column
(Sephadex G-25 column prepared in a 1-ml penicillin syringe) equilibrated with the assay buffer (e.g. 20 mM
HEPES-TMAH (pH 7.5), 25 mM salt) and centrifuged at 2,000 rpm for 30 s just before use. The recovery of liposomes was 60 to
75% as monitored by A550. In some cases, the
liposome preparation thus prepared (2 ml) was sonified for 2 min
(i.e. 1 min/ml) in a cycling mode (for 1 min followed by a
1-min interval) using a probe-type sonifier (Branson Cell Disrupter
200) equipped with a 7-mm titanium probe, with power output set at 5 (continuous mode) under an Argon atmosphere on ice to prepare liposomes
composed mostly of small unilamellar vesicles according to Sarti
et al. (23).
Fluorescent Assay of Intraliposomal pH and Transmembrane
Potential--
Intraliposomal pH was monitored by the fluorescence of
pyranine incorporated in the liposomes during their preparation (24, 25). Liposome suspensions for this experiment were prepared in a buffer
containing 500 µM pyranine. The amount of liposome suspension added to the 2-ml buffer was usually 50 µl (final, 0.60 ~ 0.67 mg of phospholipids/ml). The fluorescence of pyranine was
monitored at an excitation wavelength of 450 nm and emission wavelength
of 510 nm with a 5.0-nm slit width for both monochrometers. Membrane
potential formation was monitored either by the fluorescence quenching
of diS-C3-(5) for inside negative potential (19) or oxonol-V for inside positive potential (27), respectively, at excitation wavelengths of 620 and 580 nm and emission wavelengths of
670 and 620 nm, for diS-C3-(5) and oxonol-V,
respectively, with a 5.0-nm slit width for both
monochrometers.
Uptake of [36Cl] into Liposomes--
Uptake
experiments of [36Cl] into liposomes were performed by
the rapid gel filtration method (28). Briefly, 250 µl of the liposome
preparation (A550 = 0.24; 28 mg of
phosphatidylcholine/ml) containing pyranine prepared in 20 mM HEPES-TMAH (pH 7.5), 5 mM potassium
gluconate, and 2.5 mM MgSO4, and filtered
through Sephadex G-25 equilibrated with the assay buffer with gluconate
in place of chloride (20 mM MES-TMAH (pH 6.0), 5 mM potassium gluconate) was incubated in the same volume
(250 µl) of the buffer (20 mM MES-TMAH (pH 6.0), 5 mM NaCl, containing Na[36Cl] (0.1 µCi/ml))
at 25 or 37 °C, inhibitor added (tributyltin chloride (TBT) or one
of the prodigiosins) at 1 min and the mixture further incubated for the
indicated period. After incubation, 400 µl of the incubation mixture
was applied onto Dowex 1-X8 ion-exchanging resin (Cl
form, prepared in a 1-ml syringe) equilibrated with the assay buffer,
centrifuged at 2,000 rpm for 3 min, and the radioactivity of
[36Cl] in 200 µl of the eluate was measured in a liquid
scintillation counter (Aloka) in a vial containing 10 ml of
ClearsolTM. All data are the averages (mean ± S.D.)
of triplicate experiments.
Other Analytical Methods--
Protein level was determined by
the Amido Black/solid phase method of Schaffner and Weissmann (29) or
Coomassie Brilliant Blue/liquid phase method of Bradford (30) using the
Bio-Rad protein assay kit according to the manufacture's instruction
manual, with bovine serum albumin as the standard.
 |
RESULTS |
Prodigiosins Inhibit Acidification, but Affect Neither ATP
Hydrolysis nor Membrane Potential Formation Mediated by V-ATPase
Prodigiosins have a general structure of
methoxybipyrrolopyrromethene with hydrocarbon side chain(s) attached to
the "right-hand" pyrrole ring. In this study, we used prodigiosin,
metacycloprodigiosin, and prodigiosin 25-C (Fig.
1) but present the results of
metacycloprodigiosin in most cases because the results were almost the
same among the three prodigiosins. In the previous paper (8), we showed
that prodigiosin 25-C increased lysosomal pH in cultured cells as a result of its uncoupling activity on the lysosomal
H+-ATPase (V-ATPase), although prodigiosin 25-C uncoupled
F-ATPases, too. Fig. 2A shows
the dose responses of the effect of metacycloprodigiosin, as compared
with bafilomycin A1, on the acidification, bafilomycin A1-sensitive ATPase, and membrane potential formation of
lysosomal V-ATPase. Metacycloprodigiosin (and prodigiosin), like
prodigiosin 25-C, inhibited acidification with an IC50 of
5 ~ 20 nM (at 170 µg of protein/ml; corresponding
to 30 ~ 120 pmol/mg of protein) but hardly affected ATPase
activity up to ~1 µM (>50 ~ 100 times that of
the IC50 acidification inhibition). This contrasts with the
effect of bafilomycins which inhibit both acidification and ATPase
activities with an IC50 of about 1 nM (Fig.
2B; for bafilomycin A1). Furthermore,
prodigiosins did not affect the membrane potential formation
of V-ATPase either (Fig. 2A, for metacycloprodigiosin), which also contrasts with the effect of bafilomycins (IC50
inhibition of membrane potential formation ~1 nM) (Fig.
2B; for bafilomycin A1). This feature is unique
to prodigiosins and not shared by the other basic substances tested so
far in our laboratory. The insensitivity to prodigiosins of ATPase and
membrane potential formation was shared also with F-ATPases
(mitochondrial and bacterial H+-ATPases).2

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
Effects of metacycloprodigiosin
(A) as compared with bafilomycin A1
(B) on acidification, bafilomycin A1-sensitive
ATPase, and membrane potential formation of isolated lysosomes.
Acidification and membrane potential formation of lysosomes were
measured using dextranosomes loaded with FD as described under
"Experimental Procedures" in buffers (20 mM HEPES-TMAH
(pH 7.5), 0.1 M KCl, 0.2 M sucrose, 0.5 mM MgCl2, and diS-C3-(5)) with or
without the indicated concentrations of inhibitors (1%
Me2SO as solvent control) added 1 min before the addition
of 1 mM ATP-Na2. Bafilomycin
A1-sensitive ATPase activity of lysosomes was measured
using TMG solubilized with
n-octyl- -D-thioglucoside (15, 27) as
described under "Experimental Procedures" in buffers with or
without the indicated concentrations of inhibitors (1%
Me2SO as solvent control). The ATPase reaction (for 40 min
at 30 °C) was started by the addition of enzyme.
|
|
The inability of prodigiosins to inhibit membrane potential formation
suggests that they functionally: 1) inhibit transformation of
 (driven by V-ATPase) into pH (31); 2) change the participating ion from H+ to another cation, either through ionophoric
activity (of say nigericin, a H+/K+ exchange
ionophore) or by changing the ion specificity of the ATPase (like (V or
F)-type Na+-ATPase or respiratory Na+ pump)
(32-34); or 3) change the participating ion from H+ (or
OH ) to another anion either through ionophoric activity
(for example, TBT, a OH /Cl exchanger (35)),
or by changing the ion specificity of the ATPase (like the relationship
between halorhodopsin and bacteriorhodopsin (36)). But, the
prodigiosins did not show any ionophoric activity against
H+ and/or K+ (8). Therefore,
H+/Cl symport (or
OH /Cl exchange) activity was suspected. In
fact, their activity to inhibit vesicular acidification required
chloride (with no obvious saturation), even in the presence of
K+-valinomycin added to the assay buffer to dissipate
 and to eliminate possible participation of chloride
channel(s).2,3 On the basis
of these observations, we next tested if prodigiosins show
H+/Cl symport (or
OH /Cl exchange) activity on phospholipid
membranes using liposomes that are devoid of proton pump protein.
H+/Cl- Symport
(OH-/Cl- exchange) Activity of Prodigiosins on
Liposomes
Prodigiosins Produced Chloride Gradient-dependent
Perturbation of Intraliposomal pH--
Depending on the preliminary
observations, we performed a direct assay of the
H+/Cl symport activity of prodigiosins by
measuring the effect of prodigiosins on the
chloride-dependent change of internal pH of the liposomes (Fig. 3). In Fig. 3A,
liposomes containing the pH-sensitive fluorescent probe pyranine (24)
prepared in KCl were diluted 40-fold in external buffer containing
either gluconate (sodium gluconate) or chloride (NaCl). In control
experiments, Me2SO or EtOH (solvent control), added instead
of prodigiosins or TBT, did not produce significant change in the
fluorescence, and the addition of MES-TMAH produced a rapid decrease in
fluorescence to a certain extent (indicative of the presence of
non-trapped extraliposomal pyranine) followed by a slow gradual
decrease of fluorescence (indicating acidification of the liposome
interior), suggesting limited permeability of liposomal membranes to
protons (or hydroxyl anions). On the other hand, metacycloprodigiosin
(1 µM), like TBT (100 nM), produced a rapid
increase in the pyranine fluorescence (indicating internal alkalinization) in gluconate buffer but not in chloride buffer. However, the addition of MES-TMAH (pH 6.0) produced a marked decrease of pyranine fluorescence (indicating intraliposomal acidification) in
prodigiosin- or TBT-treated liposomes relative to control
(Me2SO or EtOH), and the rate of this decrease was greater
in chloride than in gluconate buffer.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 3.
Chloride gradient-dependent
changes of intraliposomal pH produced by metacycloprodigiosin and
TBT. Liposomes containing pyranine, prepared in a buffer (20 mM HEPES-TMAH, pH 7.5) containing either (A) KCl
(25 mM KCl, 2.5 mM MgCl2)
(Cl--containing liposomes) or (B) potassium
gluconate (25 mM potassium gluconate, 2.5 mM
MgSO4) (Cl--free liposomes) were diluted
40-fold in external buffer (20 mM HEPES-TMAH, pH 7.5)
containing either 25 mM sodium gluconate or NaCl and the
pyranine fluorescence was recorded as described under "Experimental
Procedures." A, Cl--containing liposomes.
MES-TMAH (pH 6.0), 50 mM; TX-100,
0.2% Triton X-100; Meta, 100 nM
metacycloprodigiosin; TBT, 1 µM; DMSO, 1%
Me2SO (solvent control for metacycloprodigiosin) in sodium
gluconate buffer (dashed line); EtOH, 1% EtOH
(solvent control for TBT) in sodium gluconate buffer (dashed line).
B, Cl--free liposomes. MES-TMAH (pH
6.0), 50 mM; TX-100, 0.2% Triton X-100;
Meta, 1 µM metacycloprodigiosin;
TBT, 100 nM; DMSO, 1%
Me2SO (solvent control for metacycloprodigiosin) in NaCl
buffer (dashed line); EtOH, 1% EtOH (solvent
control for TBT) in NaCl buffer (dashed line).
|
|
Likewise, when pyranine-containing liposomes prepared in a buffer
containing potassium gluconate (and MgSO4) in place of KCl (and MgCl2) were diluted in external buffer containing
either gluconate (sodium gluconate) or chloride (NaCl),
metacycloprodigiosin (1 µM), like TBT (100 nM), produced a rapid decrease in the pyranine fluorescence
(indicating internal acidification) in chloride more than in gluconate
(Fig. 3B). The addition of MES-TMAH (pH 6.0) produced a
further decrease of pyranine fluorescence in prodigiosin- or
TBT-treated liposomes relative to control (Me2SO or EtOH), and the rate of this decrease was greater in chloride than in gluconate
buffer. But also note that the rate of this decrease was not zero in
gluconate, and greater in prodigiosin- than TBT-treated liposomes.
Essentially the same results were obtained with prodigiosin 25-C and
prodigiosin (see below). In additional control experiments, 1 µM NH4Cl did not show such activity, while
nigericin produced a quick fluorescent decrease indicative of
intraliposomal acidification due to external H+/internal
K+ exchange.
Dependence of the Prodigiosin-mediated Liposomal Acidification on
External Chloride Ion--
In Fig.
4A, pyranine-containing
liposomes prepared in potassium gluconate were diluted 40-fold in
external buffer consisting of different ratios (1:0, 1:1, 1:3, 1:7, and
0:1) of NaCl and sodium gluconate. The results clearly show that both
metacycloprodigiosin and TBT acidified intraliposomal pH almost
linearly with no obvious saturation dependent on the chloride
concentration as summarized in Fig. 4B: again note that the
rate of the acidification in gluconate was greater in prodigiosin- than
TBT-treated liposomes. This result is also consistent with the
ionophoric nature of intraliposomal acidification driven by
prodigiosins. In order of effectiveness, the inhibitors ranked as
follows: TBT > prodigiosin, metacycloprodigiosin > prodigiosin 25-C: the effective concentrations in chloride buffer for
50% of maximum fluorescence quenching in 10 s were 1.0, 0.7, and
9.0 nmol/mg phospholipid for prodigiosin, metacycloprodigiosin, and
prodigiosin 25-C, respectively, as compared with 23 pmol/mg phospholipid for TBT.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 4.
Chloride dose responses of intraliposomal
acidification mediated by metacycloprodigiosin and TBT. Liposomes
containing pyranine, prepared in 20 mM HEPES-TMAH (pH 7.5),
25 mM potassium gluconate, and 2.5 mM
MgSO4 were diluted 50-fold in external buffer (20 mM HEPES-TMAH (pH 7.5) containing 25 mM NaCl or
sodium gluconate (pH 7.5), alone or in combination at ratio of 1:0,
1:1, 1:3, 1:7, or 0:1, respectively) and the pyranine fluorescence was
recorded as described under "Experimental Procedures." At the times
indicated (arrows), 100 nM of either
metacycloprodigiosin (1% M2SO as solvent control)
(top) or TBT (1% EtOH as solvent control)
(bottom) was added. A, fluorescence trace.
Meta, 100 nM metacycloprodigiosin;
TBT, 100 nM; TX-100, 0.2% Triton
X-100; DMSO, 1% Me2SO in NaCl buffer;
EtOH, 1% EtOH in NaCl buffer. B, chloride
dose-response. Rates of acidification (% of maximum values) are
plotted against mol % of Cl in Cl/gluconate
buffer.
|
|
Electroneutral Nature of the Prodigiosin-catalyzed
H+/Cl- Symport--
In Fig.
5, pyranine-containing liposomes prepared in KCl
(and MgCl2) at pH 6.0 were first diluted 40-fold in
external buffer of either sodium gluconate or potassium gluconate (pH
7.5), then added with 5 µM valinomycin followed by
prodigiosin (1 µM) or TBT (100 nM) to see the
effect of inside-negative membrane potential generated by the addition
of valinomycin on the prodigiosin- and TBT-induced liposomal
alkalinization. The rate of increase of fluorescence after the addition
of prodigiosin was slightly accelerated by the presence of
valinomycin (Fig. 5A). However, this occurred irrespective of the cation species (sodium or potassium) (with the
relative extent of the acceleration being unchanged), similarly to TBT
(Fig. 5IB) the electroneutrality of whose action has been well
established (37, 38). The membrane potential measured by the
fluorescence of diS-C3-(5) and oxonol-V also suggested little membrane potential difference produced by prodigiosins. These
results suggest that the H+/Cl symport (or
OH /Cl antiport) mediated by prodigiosin
is electroneutral in essence.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Electroneutrality of intraliposomal
alkalinization induced by metacycloprodigiosin (A) and TBT
(B). Potassium-loaded liposomes containing pyranine
were prepared from phosphatidylcholine (100 mg) in 2.0 ml of 25 mM KCl, 20 mM HEPES-TMAH (pH 7.5), and 500 µM pyranine, diluted 50-fold into 2 ml of assay buffer
consisting of 20 mM HEPES-TMAH (pH 7.5) and 25 mM solution of either sodium gluconate or potassium
gluconate, and the pyranine fluorescence was recorded as described
under "Experimental Procedures" in the presence or absence of
valinomycin. Meta, 1 µM metacycloprodigiosin;
TBT, 100 nM; TX, 0.2% Triton X-100;
Val, 5 µM valinomycin; DMSO, 1%
Me2SO (solvent control for metacycloprodigiosin) in sodium
gluconate buffer; EtOH, 1% EtOH (solvent control for TBT)
in sodium gluconate buffer.
|
|
Prodigiosin-mediated Chloride Transport in Liposomes Measured using
[36Cl]--
To obtain direct evidence that prodigiosins
possess activity to promote the movement of chloride across membranes,
we first tried to extract chloride with organic solvent. Like TBT and
manganese porphyrin (a recently reported chloride ionophore (39, 40)), prodigiosins showed some, albeit weak, activity to mediate the movement
of chloride into organic solvent, notably at acidic pH (data not
shown). However, the phase transfer activity of prodigiosins does not
necessarily explain their "catalytic activity" to promote transport
of Cl across membranes coupled with H+ (or in
exchange with OH ). So, we next measured
[36Cl] movement in parallel with the change in
intraliposomal pH. As shown in Fig. 6, all three
prodigiosins tested, like TBT, mediated dose- and
time-dependent uptake of chloride into liposomes coupled with concomitant intraliposomal acidification (indicating uptake of
H+ or extrusion of OH ). Among the
prodigiosins tested, prodigiosin and metacycloprodigiosin are the
most potent with prodigiosin 25-C having about half their activity.
Fig. 7 shows the pH dependence of intraliposomal
uptake of [36Cl] and H+ promoted by
metacycloprodigiosin and TBT. The results show an accelerated uptake of
both [36Cl] and H+ at acidic pH for both
metacycloprodigiosin and TBT, although slight differences are noted
between metacycloprodigiosin and TBT in pH dependence. The temperature
dependence of the uptake of [36Cl] into liposomes
indicated an activation energy of about 15 ~ 16 kcal/mol for
both metacycloprodigiosin and TBT which matched with the value
reported for TBT (41).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 6.
Concomitant uptake of chloride
[36Cl] (A) and proton (or
extrusion of hydroxyl ion) (B) into liposomes mediated by
prodigiosins and TBT. Uptake of [36Cl] into
liposomes was performed according to "Experimental Procedures."
Briefly, potassium-loaded liposomes (50 mg/ml) containing 500 µM pyranine prepared in 20 mM HEPES-TMAH (pH
7.5), 5 mM potassium gluconate and 2.5 mM
MgSO4 were centrifuged through Sephadex G-25 equilibrated
with 20 mM MES-TMAH (pH 6.0) and 5 mM KCl and
the eluate was used for the experiments as liposome suspension (28 mg
of phospholipids/ml). The assay buffer contained 20 mM
MES-TMAH (pH 6.0), 5 mM KCl, and Na[36Cl]
(0.1 µCi/ml). 250 µl each of the above liposome suspension and
assay buffer were mixed and the reaction started at 37 °C. At 1 min,
5 µl of either prodigiosins (1% Me2SO as solvent
control) or TBT (1% EtOH as solvent control) was added to the assay
buffer to attain the indicated final concentrations. Mean ± S.D.
of triplicates are plotted. Fluorescence assays were performed as
described under Fig. 3, after dilution of 40 µl of the above liposome
suspension into the above assay buffer. DMSO, 1%
Me2SO; EtOH, 1% EtOH; PG,
prodigiosin; 25-C, prodigiosin 25-C; Meta,
metacycloprodigiosin; TX-100, 0.2% Triton X-100.
|
|

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 7.
pH dependence of the uptake of
(A) chloride [36Cl] and
(B) proton into liposomes mediated by
metacycloprodigiosin and TBT. Preparation of pyranine-containing,
potassium-loaded liposomes and the uptake assays of
[36Cl] and proton were as described in the legend to Fig.
6, except that the pH of the assay buffer was either 6.0 (20 mM MES-TMAH), 7.0 (20 mM HEPES-TMAH) or 8.0 (20 mM Bicine-TMAH). Mean ± S.D. of triplicates are
plotted. Meta, 1 µM metacycloprodigiosin;
TBT, 1 µM TBT; DMSO, 1%
Me2SO (solvent control for metacycloprodigiosin);
EtOH, 1% EtOH (solvent control for TBT).
|
|
 |
DISCUSSION |
In recent years, there have been several important findings
regarding the mechanism of energy transduction, some relating to
structural biology (for F0F1-ATPase (42) and
cytochrome oxidase complexes (43, 44)), others to combined molecular
fluorescence micromanipulation technology (45) (showing molecular spin
of H+-ATPase molecules). Nevertheless, one important aspect
of energy transduction, "energy coupling," remains to be clarified.
From a biochemical point of view, specific modifiers of energy
transduction would represent a breakthrough, just as uncouplers opened
the way to the chemiosmotic hypothesis of Mitchell in 1961.
Prodigiosins were initially thought of as candidates of such modifiers
to help elucidate the energy transduction mechanism: prodigiosins
inhibited the acidification mediated by various
H+-translocating ATPases without inhibiting ATP hydrolysis
nor membrane potential formation (8) (Fig. 2), unlike ordinary
uncouplers of oxidative phosphorylation or ATPase inhibitors. However,
evidence has been accumulating that prodigiosins have an ionophoric
nature and we demonstrated in the present study that prodigiosins act as a H+/Cl symporter (or
OH /Cl antiporter, in its equivalence) on
liposomes, by showing: 1) alkalinization and acidification of
intraliposomal pH depending on the outward and inward chloride
gradient, respectively; 2) the electroneutrality of their effects; and
finally, 3) the pH gradient (outside acid)-dependent uptake
of radioactive chloride into liposomes in parallel with intraliposomal
acidification.
These results on the whole favor the idea that the uncoupling effect of
prodigiosins is due to their H+/Cl symport
activity across biological membranes. In fact, their effective
concentrations for H+/Cl symporting activity
on liposomes decreased in parallel with the amount of phospholipid
used, and were comparable to those on organellar membranes (8) when
expressed on the basis of the amount of vesicles used (in the order of
nmol/mg: for 50% maximum pH change in 10 s).2 The
possibility of specific interaction of prodigiosins with H+-translocators is, however, not completely
excluded, especially at higher concentrations where they inhibited
catalytic (ATPase) activity. Studies are now in progress to unravel the
mode of direct interaction between prodigiosins and the enzymes. The
reason for the much higher effectiveness of TBT on liposomes (Figs. 4
and 6)2,3 is not clear. It may reflect difference of
permeability against the ionophore between liposomes and organellar
membranes due to compositional differences (for example, absence or
presence of proteins).
The H+/Cl symport (or
OH /Cl antiport) activity of prodigiosins
also explains several previous findings: 1) that the ATP level was
hardly affected by prodigiosin 25-C; 2) mitochondrial swelling induced
by prodigiosin 25-C, and so on. As prodigiosins did not affect the
membrane potential formation, they are not expected to affect ATP
formation in mitochondria where the proton motive force is stored
mainly in the form of transmembrane potential. In this regard,
prodigiosins are quite similar to the traditional OH /Cl exchangers, triorganotins (for
example, TBT), which inhibit vesicular acidification but hardly affect
membrane potential formation in reconstituted cytochrome oxidase
proteoliposomes (46) nor ATP formation in the photophosphorylation
driven by halorhodopsin (47). Like prodigiosins, triorganotins
induce mitochondrial swelling (48, 49), which is explained by the
uptake of osmotically active Cl in exchange for
respiration-induced OH (equivalent to coupled transport
of Cl with respiration-induced H+). However,
triorganotins act, at the same time, as uncouplers of oxidative
phosphorylation and inhibit mitochondrial ATP formation, because they
inhibit the F-ATPase molecules themselves through SH-protecting reagent
(for example, N-ethylmaleimide)-sensitive binding (46,
50-54)). In fact, the effect of TBT on the acidification by
H+-ATPases was not suppressed by the presence of large
amounts of liposomes, contrary to the effect of
prodigiosins.4 Golgi swelling
might be due to pH-induced accumulation of osmotically active
protonated weak bases (prodigiosins) within the Golgi apparatus. Golgi,
rather than lysosomes swell possibly because Golgi membranes are less
permeable to K+ (19, 55), resulting in more
Cl uptake than K+ extrusion.
The nature of prodigiosins as H+/Cl
symporters also suggests that there are additional translocators or
biological activities affected by prodigiosins: they will include
respiratory proton pumps, vacuolar H+-translocating
pyrophosphatases, ATP-dependent transhydrogenases of
NADP+ and NADH, H+- or
Cl -transporting bacterio/halo-rhodopsins,
H+(OH )- or Cl -coupled
symporters or antiporters, and Cl -pumps. Prodigiosins may
prove useful for the clarification of ion transport mechanisms.
What is the mechanism of H+/Cl symport (or
OH /Cl antiport) of prodigiosins? Organotins
are considered to support the exchange of halides with OH
across membranes due to their covalent bonding (co-ordination) with
halides on one side of the membrane accompanied by their hydrolyses on
the other side (41, 57, 58). Prodigiosins, on the other hand, probably
bind with halides electrostatically in accordance with
Hofmeister series (possibly helped by the stabilizing effect of
hydrogen-bonding and/or charge transfer (59, 60) interactions of
protonated nitrogen in prodigiosins), resulting in the formation of
lipophilic ion pairs which facilitate proton-coupled transmembrane
transport of halides as do phase transfer catalysts (61, 62). In this
sense, prodigiosins are probably
H+/Cl-
symporters rather than OH /Cl
exchangers: protonated prodigiosins are less likely to bind
OH , especially at acidic pH. In addition, prodigiosins
show anion specificity similar to that of TBT but with some important
differences: for example, gluconate prefers prodigiosins to TBT (Figs.
3 and 4). Studies on the crystallographic structure of prodigiosin
salts as well as on the structure-activity relationship will help
clarify the essential structures and the action mechanism of these new H+/Cl symporters.
Several other new H+/Cl symporters (or
OH /Cl exchangers) have been reported
recently. They include thallium chloride (Tl3+,
e.g. TlCl3) (63), bepridil (64),
Hg2+ and Cu+ (65), sapphyrin (66), and cryptate
(67). Also, the number of new Cl sensing ionophores has
been accumulating: they include Mn2+-porphyrin (39, 40),
pamamycin (68), mercury organic compounds (ETH 9018 (69)), besides
methyltributylammonium chloride, tetrabutylammonium chloride, and
tridodecylmethylammonium chloride, some of which may exhibit
H+/Cl symporting
(OH /Cl antiporting) activity, too.
The activity of prodigiosins presented in this article suggests that
these anion-exchanging compounds constitute a new group of probes for
the analysis of vacuolar function, as their effects are relatively
selective to vacuolar pH in vivo, hardly affecting the
cellular ATP level. Namely, we can expect that they affect all aspects
of cellular functions involving V-ATPase, including endocytosis,
exocytosis, and intracellular trafficking as well as cell growth, cell
differentiation, and cell death (apoptosis). In fact, we have already
reported suppressive activity of prodigiosins on various aspects of
immunity and bone resorption (2-7). Also, we can expect
prodigiosin-specific reactions, because prodigiosins do not seriously
affect membrane potential formation: for example, they selectively
inhibit pH-dependent uptake of certain neurotransmitters (like dopamine or histamine) without affecting  dependent uptake of other neurotransmitters (like glutamate) into synaptic vesicles (70). In summary, we have now three different types of vacuolar perturbators in hand: 1) weak bases and acidic ionophores which raise
the pH and induce swelling of the vacuolar system; 2) prodigiosin group
H+/Cl symporters that affect only vacuolar
pH; and 3) bafilomycin group antibiotics (including concanamycins and
destruxins) that affect both pH and membrane potential formation. By
proper application of these probes, we will be able to clarify much
more extensively the unknown functions of the vacuolar system.
Furthermore, the H+/Cl symport activity of
the compounds reported in this study may actually be a sort of
"missing link" and should be taken seriously, especially in regard
to therapeutic drugs.
Finally, prodigiosins are also interesting from the point of view of
organic synthesis, because they are small enough for chemical
modifications aimed at providing more active and less toxic compounds.
Although their synthetic history is long (71-74), a simple and elegant
way to synthesize prodigiosins was reported recently (75) which will
help in the synthesis of new active derivatives.
 |
ACKNOWLEDGEMENTS |
We are grateful to K. Hirano, A. Kojima, and
A. Hayashi (Faculty of Pharmaceutical Sciences, Kanazawa University)
for excellent technical assistance. Thanks are also due to Drs. N. Hirayama (Faculty of Science, Kanazawa University), K. Yokoyama, and K. Arai (Faculty of Pharmaceutical Sciences, Kanazawa University) for
valuable discussions. Finally, we express our special thanks to Prof.
Emeritus Y. Anraku (Graduate School of Science, The University of
Tokyo) for critical reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by a Grant-in-Aid from the Ministry
of Education, Science, and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Laboratory of
Biochemistry, Dept. of Molecular and Cell Biology, Faculty of
Pharmaceutical Sciences, Kanazawa University, Takara-machi 13-1, Kanazawa, Ishikawa 920-0934, Japan, Fax: 81-76-234-4462; E-mail:
ohkuma{at}kenroku.kanazawa-u.ac.jp.
The abbreviations used are:
MES, 2-(N-morpholino)-ethanesulfonic aciddiS-C3-(5), dipropylthiodicarbocyanine iodideDTT, dithiothreitolF-ATPase, F-type H+-ATPaseFD, fluorescein-labeled dextran , transmembrane potential pH, transmembrane pH gradientoxonol-V, bis(3-phenyl-5-oxoisoxazol-4-yl)pentamethine oxonolP-ATPase, P-type
H+-ATPaseTMAH, tetramethylammonium hydroxideTBT, tributyltin chlorideBicine, N,N-bis(2-hydroxyethyl)glycine.
2
H. Konno, H. Matsuya, M. Okamoto, T. Sato, Y. Tanaka, K. Yokoyama, T. Kataoka, K. Nagai, H. H. Wasserman, and S. Ohkuma, manuscript in preparation.
3
S. Ohkuma, T. Sato, M. Okamoto, H. Matsuya, K. Arai, T. Kataoka, K. Nagai, and H. H. Wasserman, manuscript in
preparation.
4
T. Sato, Y. Tanaka, and S. Ohkuma, unpublished
observation.
 |
REFERENCES |
-
Williams, R. P.,
and Hearn, W. R.
(1967)
in
Antibiotics (Gottlieb, D., and Shaw, P. D., eds), Vol. 2, pp. 410-432, Springer-Verlag, Berlin
-
Nakamura, A.,
Nagai, K.,
Ando, K.,
and Tamura, G.
(1986)
J. Antibiot.
39,
1155-1159[Medline]
[Order article via Infotrieve]
-
Kataoka, T.,
Magae, J.,
Kasamo, K.,
Yamanishi, H.,
Endo, A.,
Yamasaki, M.,
and Nagai, K.
(1992)
J. Antibiot.
45,
1618-1625[Medline]
[Order article via Infotrieve]
-
Lee, M.-H.,
Kataoka, T.,
Magae, J.,
and Nagai, K.
(1995)
Biosci. Biotech. Biochem.
59,
1417-1421[Medline]
[Order article via Infotrieve]
-
Magae, J.,
Miller, M. W.,
Nagai, K.,
and Shearer, G. M.
(1996)
J. Antibiot.
49,
86-90[Medline]
[Order article via Infotrieve]
-
Nakamura, A.,
Magae, J.,
Tsuji, R. F.,
Yamasaki, M.,
and Nagai, K.
(1989)
Transplantation
47,
1013-1016[Medline]
[Order article via Infotrieve]
-
Woo, J.-T.,
Ohba, Y.,
Tagami, K.,
Sumitani, K.,
Kataoka, T.,
and Nagai, K.
(1997)
Biosci. Biotech. Biochem.
61,
400-402[Medline]
[Order article via Infotrieve]
-
Kataoka, T.,
Muroi, M.,
Ohkuma, S.,
Waritani, T.,
Magae, J.,
Takatsuki, A.,
Kondo, S.,
Yamasaki, M.,
and Nagai, K.
(1995)
FEBS Lett.
359,
53-59[CrossRef][Medline]
[Order article via Infotrieve]
-
Ohkuma, S.,
Matsuya, H.,
Okamoto, M.,
Honno, H.,
Sato, T.,
Kataoka, T.,
and Nagai, K.
(1996)
Jpn. Bioenerg. Group Abst.
22,
28-29
-
Wasserman, H. H., McKeon, J. E., Smith, L. A., and
Forgione, P. (1966) Tetrahedron Suppl. 8, Part II,
647-662
-
Harashima, K.,
Tsuchida, N.,
Tanaka, T.,
and Nagatsu, J.
(1967)
Agric. Biol. Chem.
31,
481-489
-
Grabe, C. G.,
Harty, P. K.,
and Rosen, S. D.
(1983)
Anal. Biochem.
130,
287-294[CrossRef][Medline]
[Order article via Infotrieve]
-
Arai, K.,
Kanaseki, T.,
and Ohkuma, S.
(1991)
J. Biochem. (Tokyo)
110,
541-547[Abstract/Free Full Text]
-
Moriyama, Y.,
and Nelson, N.
(1987)
J. Biol. Chem.
262,
9175-9180[Abstract/Free Full Text]
-
Arai, K.,
Shimaya, A.,
Hiratani, N.,
and Ohkuma, S.
(1993)
J. Biol. Chem.
268,
5649-5660[Abstract/Free Full Text]
-
Ohkuma, S.,
Moriyama, Y.,
and Takano, T.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
2758-2762[Abstract/Free Full Text]
-
Ohkuma, S.
(1989)
Methods Enzymol.
174,
131-154[Medline]
[Order article via Infotrieve]
-
Ohkuma, S.,
and Takano, T.
(1997)
Cell Struct. Funct.
22,
253-268[Medline]
[Order article via Infotrieve]
-
Ohkuma, S.,
Moriyama, Y.,
and Takano, T.
(1983)
J. Biochem. (Tokyo)
94,
1935-1943[Abstract/Free Full Text]
-
Chan, K.-M.,
Delfert, D.,
and Junger, K. D.
(1986)
Anal. Biochem.
157,
375-380[CrossRef][Medline]
[Order article via Infotrieve]
-
Kasahara, M.,
and Hinkle, P. C.
(1977)
J. Biol. Chem.
252,
7384-7390[Free Full Text]
-
Sase, S.,
Anraku, Y.,
Nagano, M.,
Osumi, M.,
and Kasahara, M.
(1982)
J. Biol. Chem.
257,
11100-11105[Abstract/Free Full Text]
-
Sarti, P.,
Molinari, A.,
Arancia, G.,
Meloni, A.,
and Citro, G.
(1995)
Biochem. J.
312,
643-648
-
Kano, K.,
and Fendler, J. H.
(1978)
Biochim. Biophys. Acta
509,
289-299[Medline]
[Order article via Infotrieve]
-
Clement, N. R.,
and Gould, J. M.
(1981)
Biochemistry
20,
1534-1538[CrossRef][Medline]
[Order article via Infotrieve]
-
Deleted in proof
-
Moriyama, Y.,
Takano, T.,
and Ohkuma, S.
(1984)
J. Biochem. (Tokyo)
95,
995-1007[Abstract/Free Full Text]
-
Verkman, A. S.,
Takls, R.,
Sefton, B.,
Basbaum, C.,
and Widdicombe, J. H.
(1989)
Biochemistry
28,
4240-4244[CrossRef][Medline]
[Order article via Infotrieve]
-
Schaffner, W.,
and Weissmann, C.
(1973)
Anal. Biochem.
56,
502-514[CrossRef][Medline]
[Order article via Infotrieve]
-
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
-
Higuti, T.
(1993)
in
New Functionality Materials: Design, Preparation and Control (Tsuruta, T., Seno, M., and Doyama, M., eds), pp. 131-138, Elsevier Science Publishers, B. V., Amsterdam
-
Kalm, G.,
and Dimroth, P.
(1995)
J. Mol. Biol.
253,
726-738[CrossRef][Medline]
[Order article via Infotrieve]
-
Kakinuma, Y.,
Kakinuma, S.,
Takase, K.,
Konishi, K.,
Igarashi, K.,
and Yamato, I.
(1993)
Biochem. Biophys. Res. Commun.
195,
1063-1069[CrossRef][Medline]
[Order article via Infotrieve]
-
Udagawa, T.,
Unemoto, T.,
and Tokuda, H.
(1986)
J. Biol. Chem.
261,
2616-2622[Abstract/Free Full Text]
-
Selwyn, M. J.,
Dawson, A. P.,
Stockdale, M.,
and Gains, N.
(1970)
Eur. J. Biochem.
14,
120-126[Medline]
[Order article via Infotrieve]
-
Sasaki, J.,
Brown, L. S.,
Chon, Y.-S.,
Kandori, H.,
Maeda, A.,
Needleman, R.,
and Lanyi, J. K.
(1995)
Science
269,
73-75[Abstract/Free Full Text]
-
Singh, A. P.,
and Nichols, P.
(1986)
Biochem. Cell Biol.
64,
647-655[Medline]
[Order article via Infotrieve]
-
Antonenko, Y. N.
(1990)
J. Membr. Biol.
113,
109-113[CrossRef][Medline]
[Order article via Infotrieve]
-
Chaniotakis, N. A.,
Chasser, A. M.,
Meyerhoff, M. E.,
and Groves, J. T.
(1988)
Anal. Chem.
60,
185-188[Medline]
[Order article via Infotrieve]
-
El-Etri, M.,
and Cuppoletti, J.
(1996)
Am. J. Physiol.
270,
L386-L392[Abstract/Free Full Text]
-
Wieth, J. O.,
and Tosteson, M. T.
(1979)
J. Gen. Physiol.
73,
765-788[Abstract/Free Full Text]
-
Abrahams, J. P.,
Leslie, A. G. W.,
Lutter, R.,
and Walker, J. E.
(1994)
Nature
370,
621-628[CrossRef][Medline]
[Order article via Infotrieve]
-
Iwata, S.,
Ostermeier, C.,
Ludwig, B.,
and Michel, H.
(1995)
Nature
376,
660-669[CrossRef][Medline]
[Order article via Infotrieve]
-
Tsukihara, T.,
Aoyama, H.,
Yamashita, E.,
Tomizaki, T.,
Yamaguchi, H.,
Shinzawa-Itoh, K.,
Nakashima, R.,
Yaono, R.,
and Yoshikawa, S.
(1995)
Science
269,
1069-1074[Abstract/Free Full Text]
-
Noji, H.,
Yasuda, R.,
Yoshidaa, M.,
and Kinoshita, K., Jr.
(1997)
Nature
386,
299-302[CrossRef][Medline]
[Order article via Infotrieve]
-
Barranco, J.,
Darszon, A.,
and Gómez-Puyou, A.
(1981)
Biochem. Biophys. Res. Commun.
100,
1402-1408[CrossRef][Medline]
[Order article via Infotrieve]
-
Mukohata, Y.,
and Kaji, Y.
(1981)
Arch. Biochem. Biophys.
206,
72-76[CrossRef][Medline]
[Order article via Infotrieve]
-
Stockdale, M.,
Dawson, A. P.,
and Selwyn, M. J.
(1970)
Eur. J. Biochem.
15,
342-351[Medline]
[Order article via Infotrieve]
-
Wulf, R. G.,
and Byington, K. H.
(1975)
Arch. Biochem. Biophys.
167,
176-185[CrossRef][Medline]
[Order article via Infotrieve]
-
Gould, J. M.
(1976)
Eur. J. Biochem.
62,
567-575[Medline]
[Order article via Infotrieve]
-
Cain, K.,
and Griffiths, D. E.
(1977)
Biochem. J.
162,
575-580[Medline]
[Order article via Infotrieve]
-
Farrow, B. G.,
and Dawson, A. P.
(1978)
Eur. J. Biochem.
86,
85-95[CrossRef][Medline]
[Order article via Infotrieve]
-
Emanuel, E. L.,
Carver, M. A.,
Solani, G. C.,
and Griffiths, D. E.
(1984)
Biochim. Biophys. Acta
766,
209-214[Medline]
[Order article via Infotrieve]
-
Usta, J.,
and Griffiths, D. E.
(1993)
Appl. Organometal. Chem.
7,
193-200
-
Glickman, J.,
Croen, K.,
Kelly, S.,
and Al-Awqati, Q.
(1983)
J. Cell Biol.
97,
1303-1308[Abstract/Free Full Text]
-
Deleted in proof
-
Selwyn, M. J.,
Dawson, A. P.,
Stockdale, M.,
and Gains, N.
(1970)
Eur. J. Biochem.
14,
120-126
-
Tosteson, M. T.,
and Wieth, J. O.
(1979)
J. Gen. Physiol.
73,
789-800[Abstract/Free Full Text]
-
Nakamura, K., Yasuoka, N., Kasai, N., and Mikawa, H. (1970) Chem.
Commun. 1135-1136
-
Ash, R. P.,
Herriott, J. R.,
and Deranleau, D. A.
(1977)
J. Am. Chem. Soc.
99,
4471-4475[CrossRef][Medline]
[Order article via Infotrieve]
-
Brändström, A.
(1977)
Adv. Phys. Org. Chem.
15,
267-233
-
Starks, C. M. (1985) ACS Symp. Ser. 326, 1-7
|